Universal Health Services, Inc. (NYSE:UHS) is among the 13 Most Undervalued S&P 500 Stocks to Invest In.
On February 27, 2026, Cantor Fitzgerald lowered its price target on Universal Health Services, Inc. to $229 from $250 and maintained a Neutral rating.
On February 26, 2026, BofA raised its price target on Universal Health Services, Inc. to $215 from $190 and kept an Underperform rating. The firm updated estimates with company guidance and introduced its 2028 view but reiterated Underperform, citing above-average exposure to policy changes and weak core results. The same day, Barclays increased its price target to $268 from $262 and maintained an Overweight rating following the Q4 report. Barclays said the company posted a modest miss as acute volumes decelerated but guided 2026 EBITDA ahead of Street estimates.
On February 25, 2026, Universal Health Services, Inc. reported Q4 EPS of $5.88 versus a consensus of $5.90 and revenue of $4.49 billion compared to $4.5 billion consensus. The company expects FY26 adjusted EPS of $22.64 to $24.52 versus consensus of $23.52 and FY26 revenue of $18.42 billion to $18.79 billion compared to $18.25 billion consensus.
Universal Health Services, Inc. owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities in the United States.
READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026
